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Available online 2 June 2016Background: Myeloperoxidase (MPO) anti-neutrophil cytoplasm autoantibody (ANCA)-associated vasculitis
commonly causes life-threatening pulmonary alveolar hemorrhage or ﬁbrosis. Only a limited number of candi-
date gene variants have been explored, but hitherto, are not widely conﬁrmed. In the present study, we investi-
gated the importance of energy homeostasis associated gene (Enho) mutations and adropin deﬁciency in the
development of MPO-ANCA associated lung injury.
Methods:We analyzed the peripheral bloodmononuclear cells from 152 unrelated patients and 220 population-
matched healthy individuals for genetic variations in Enho. Functional studieswith adropin knockout (AdrKO) on
C57BL/6J mice were also performed.
Findings: Sequencing revealed six patients with p.Ser43Thr and that ﬁve patients shared Cys56Trp amino acid
substitution in Enho. Serum concentration of adropin was signiﬁcantly lower in patients than that of the healthy
subjects (P b 0.0001), especially those with Enhomutations. In vivo, homo- and heterozygous carriers of the null
adropin allele exhibited MPO-ANCA associated pulmonary alveolar hemorrhage as compared to wild-type mice.
AdrKO mice exhibit reduced eNOS (Ser1177) and Akt1 (Ser473) phosphorylation and loss of Treg cells.
Interpretation:Our ﬁndings indicate that the presence of Enhomutations or adropin-deﬁciency is a probable mo-
lecular basis for the initial events triggered in MPO-ANCA associated lung injury.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Adropin
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. This is an open access article underof small blood vessels with signiﬁcantly higher mortality rates than
other autoimmune diseases (Jones et al., 2010; Nakaya et al., 2013). In
ANCA-associated vasculitis (AAV), particularly in myeloperoxidase
(MPO)-speciﬁc ANCA-positive cases, the clinical studies have been
mainly focused on renal lesions (Jennette and Falk, 2014). However, it
has become clear that pulmonary lesions such as alveolar hemorrhage
or ﬁbrosis appear concurrently to renal lesions (Zhang et al., 2014). Fur-
thermore, there is in vitro aswell as in vivo evidence to suggest a poten-
tial pathogenic role of ANCA in pulmonary vasculitis (Falk et al., 1990;
Holguin et al., 2008), but the pathomechanisms are yet unidentiﬁed.
Additionally, a debate has ensued about whether it is an autoimmune
syndrome of a single disease entity or distinct between proteinase 3
(PR3)-AAV and MPO-AAV (Lyons et al., 2012; Hogan et al., 2006).
Several studies provide evidence of potential genetic contribution
towards AAV (Knight et al., 2008, Monach and Merkel, 2010). The
most convincing association has beenwith themajor histocompatibilitythe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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2010, Jagiello et al., 2004). The other has been suggested between AAV
and the rare Z (or null) allele of the serpin A1 gene (SERPINA1) that en-
codesα1-antitrypsin, a serine proteinase inhibitor for PR3 (Monach and
Merkel, 2010; Morris et al., 2011). Both, theHLA-DP and SERPINA1 asso-
ciations are observed unambiguously in granulomatosis patients with
polyangiitis, also positive for PR3-ANCA, but not for MPO-AAV. Thus,
the genetic etiology leading to MPO-AAV or MPO-ANCA associated
lung injury has remained elusive.
Adropin, a product of the energy homeostasis associated gene
(Enho), is a recently identiﬁed protein that has been implicated in insu-
lin resistance (Aydin et al., 2013; Kumar et al., 2008) and as a novel reg-
ulator of endothelial function (Goetze and Albrethsen, 2014; Lovren et
al., 2010). It has been reported that adropin exhibits a potential role to
protect endothelium by upregulating endothelial nitric oxide synthase
(eNOS) expression through the VEGFR2-PI3K-Akt pathways (Lovren et
al., 2010; Ganesh Kumar et al., 2012; Kessenbrock et al., 2009). Our pre-
liminary study found, human MPO-ANCA-related pulmonary hemor-
rhage displaying adropin-deﬁciency and target genes mutations.
Therefore, we hypothesized that adropin may also exert direct effects
on the endothelium in AAV and MPO-ANCA associated lung injury.
2. Materials and Methods
2.1. Study Population
We conducted a chart review for patients whowere diagnosedwith
MPO-ANCA-related vasculitis during hospitalization from February
2013 through November 2015 at the 1st Afﬁliated Hospital, 2nd Afﬁliat-
ed Hospital, Union Hospital, Mindong Afﬁliated Hospital, and Quanzhou
1st Afﬁliated Hospital, Fujian Medical University; Xiamen Hospital of
T.C.M; Afﬁliated Hospital (Group) of Putian University; China (Supple-
mentary Fig. 1). MPO-ANCA-related pulmonary vasculitis cases were
further deﬁned by the following inclusion criteria: positive MPO-
ANCA serology, open or thoracoscopic lung biopsy, evidence of vasculi-
tis in the histology, and negative serum glomerular basement
membrane antibodies. All patients were evaluated for the presence of
autoimmune antibodies including anti-nuclear antibody (ANA), MPO-
ANCA, and PR3-ANCA. According to the Japanese guideline for idiopath-
ic interstitial pneumonias, basically all interstitial pneumonia cases are
recommended to examine serum ANA, MPO-ANCA, PR3-ANCA and
other autoimmune antibody as a routine screening test to exclude the
collagen vascular disease from idiopathic interstitial pneumonias. In
the guideline, the serum MPO-ANCA level of N20 EU is suggested to be
positive. There were 152 patients included, with female predominance
(female: male ratio approximately 3:2), age from 39 to 72 years, and
themedian age was 52.5 years old. What's more, 30 cases of pulmonary
bulla (aged from 25 to 60 years old, median age 37.6 years), 34 cases of
pathologically conﬁrmed lung cancer (age from 42 to 73, median age
57.5 years), 40 cases with pneumonia (age from 36 to 70, median age
55.3 years) were included, and 220 healthy controls (aged from 35 to
60 years old, with a median age of 47.6 years) were serving as controls.
This research project was approved by the Ethics Committee of the
Fujian Medical University, which supervised the study.
2.2. Analysis of Gene Mutations
Informed consent was obtained from patients and healthy donor
controls. Blood was collected and DNA extracted using a Tiangen
Genomic extraction kit (Beijing, China). Full-length Enhowas ampliﬁed,
puriﬁed, and sequenced.
2.3. Gene Targeting in AdrKO Mice
AdrKOmicewere generated by clustered regularly interspaced short
palindromic repeats (CRISPR)-Cas9 by the Shanghai BiomodelOrganism Science & Technology Development Co., Ltd. on the C57BL/
6J background. Heterozygous males and females (AdrHET) were then
mated to produce homozygous carriers of the null Enho allele
(AdrKO). All animal experimental procedures were approved by the
Committee, use of Live Animals for Teaching and Research at Fujian
Medical University and were carried out in accordance with the Guide
for the Care and Use of Laboratory Animals. AdrKO mice and wild-
type littermates (WT) were housed in a 12 h light or dark cycle room
under controlled temperatures (23 ± 1 °C) with free access to water
and standard chow (20% kcal protein, 10% kcal fat, and 70% kcal
carbohydrates).2.4. Reference Multi-testing Algorithm
Serum levels of adropin, C-reactive protein (CRP), tumor necrosis
factor alpha (TNF-α), anti-endothelial cell antibody (AECA), osteopon-
tin (OPN), endothelin-1 (ET-1), and MPO from AdrKO, AdrHET, and
WT mice were measured using a speciﬁc enzyme-linked immunosor-
bent assay (ELISA) kit (R&D Systems, Minneapolis, MN, USA), according
to the manufacturer's protocols.2.5. RNA-seq
Transcriptome deep sequencing (RNA-seq) was performed using
total RNA isolated from lung tissue of three AdrKO and three age-
matched littermates (male F2 intercross mice). Three individuals from
each genotypic groupwere randomly selected. Total RNAwas extracted
from frozen tissue using the SV Total RNA Isolation System (Promega
Corporation,Madison,WI) according to themanufacturer's instructions.
The quantity and quality of RNA samples were assessed by Nanodrop
1000 (Thermo Fisher Scientiﬁc Inc., Wilmington, DE, USA). Total RNA
samples were sent to DRIGEN Co., Ltd. for RNA-seq library preparation
using the TruSeq SBS Kit (75 Cycles) and single end sequencing by
means of an Illumina NextSeq 500 machine (Illumina). RNA-seq reads
were quality ﬁltered using SolexaQA packages with default parameters
and a ﬁlter for the requisite length greater than 70 bp for both ends of
each read pair. Sequencing data have been submitted to the NCBI Se-
quence Read Archive.
Quality ﬁltered RNA-seq readsweremapped to themouse reference
genome, mm10, with TopHat v2.1.0. The comparisons between treated
and normal mice were made using custom Perl scripts. Genes that
showed signiﬁcant (P b 0.05) difference in transcript levelswere termed
as differentially expressed (DE) genes.2.6. Histology and Immunohistochemistry
Lungs tissue were ﬁxed in 4% formalin overnight, embedded in par-
afﬁn, sectioned at 4mmand stained with hematoxylin and eosin (H&E)
for pathology. The following antibodies were used: OPN (ABclonal,
A1361), CD3 (ABclonal, A1753), CD20 (ABclonal, A1793), CD38
(ABclonal, A1680), Ki-67 (ABclonal, A18522), CD31 (ABclonal,
A31811), and VCAM-1 (ABclonal, A0279).2.7. Western Blot Analyses
Proteins from lungs of AdrKO and age-matched littermates were
separated on 4 to 12% Tris-glycine gels and transferred to nitrocellulose
membranes. Membranes were probed with antibodies directed against
(phospho-) eNOS (ABclonal, A1548), total eNOS (ABclonal, A1796),
(phospho-T450) Akt1 (ABclonal, AP0004), (phospho-S473) Akt1
(ABclonal, AP0140), Mapk1 (ABclonal, A0229), and Gapdh (ABclonal,
AP5809).
Table 1
The clinical data of the MPO-ANCA associated lung injury with- and without-Enhomutations.
Enhomutations
Without Enhomutationsp.Ser43Thr p.Cys56Trp p.Tyr72Tyr Intron
Men/women 3/3 4/1 1/0 8/7 45/80
BVAS activity 18(10–36) 20 (15–39) 25 21(12–28) 23 (14–38)
Involvement of other organs
Kidney 6(100%) 5(100%) 1(100%) 12(80%) 96(76.8%)
Lung and kidney 6(100%) 5(100%) 1(100%) 5(33.3%) 86(68.8%)
Digestive system 2(33.3%) 2(40%) 0(0%) 2(13.3%) 13(10.4%)
Lung involvement type
Cavitating inﬁltrates 4(66.7%) 2(40%) 0(0%) 6(40%) 56(44.8%)
Interstitial ﬁbrosis 5(100%) 5(100%) 1(100%) 12(80%) 78(62.4%)
Laboratory parameters
MPO-ANCA (b20 EU) 186 (86–228) 163 (81–225) 206 159 (55–289) 172 (36–356)
Adropin (pg/mL) 33.21
(15.84–55.29)
59.83
(18.34–68.30)
36.13 98.95
(69.33–172.34)
71.79
(16.01–160.56)
Serum creatinine (58–110) mmol/L 259.3 ± 96.8 219.6 ± 83.6 105.8 234.6 ± 110.3 226.3 ± 75.9
CRP level (b5) mg/L 95.6 ± 45.2 71.3 ± 55.2 36.5 106.8 ± 55.7 85.2 ± 42.6
Hyaluronic acid (0−120) ng/mL 289(166–362) 201(93–320) 169 223 (105–332) 165(90–350)
Laminin (0−130) ng/mL 205(106–285) 152(88–205) 173 186 (102–285) 182 (155–356)
Procollagen type III (b12) ng/mL 45 (15–113) 39 (22–80) 23 19 (12–83) 29 (16–58)
Collagen type IV (0–140 ) ng/mL 255 (118–368) 216 (105–338) 165 236 (182–309) 176 (136–388)
Values are mean (±SD), median (range) or number (%) of patients.
326 F. Gao et al. / EBioMedicine 9 (2016) 324–3352.8. Localization of VEGFR2/PI3K/Akt1 and CD4/FOXP3
Immunoﬂuorescence confocal microscopy was also undertaken to
determine the correlation of VEGFR2, PI3K, and Akt1. VEGFR2 was de-
tected with rabbit anti-human antibody (Sangon, Shanghai, China)
and labelled with a goat anti-rabbit secondary antibody conjugated
either to Cy3 or FITC. PI3K was detected with a rabbit anti-human anti-
body (Wanlei, Shenyang, China) and labelled with a goat anti-rabbit
secondary antibody conjugated to Cy3. Akt1 was detected with a
mouse anti-human antibody (Sanying, Wuhan, China) and labelled
with a goat anti-mouse secondary antibody conjugated to FITC. Nuclei
were costained using 4′, 6-diamidine-2-phenylidole dihydrochloride
(DAPI).
EC was identiﬁed by staining using antiCD31 which was detected
with a rabbit antihuman antibody (Santa, USA) and labelled with a
goat anti-rabbit secondary antibody conjugated to Cy3. VCAM-1 was
detected with a mouse anti-human antibody (Santa, USA) and labelled
with a goat anti-mouse secondary antibody conjugated to FITC. And nu-
clei were costained using DAPI.
Tregs was identiﬁed by staining using antiCD4 and antiFoxp3. CD4
was detected with a rabbit antihuman antibody (Sanying, Wuhan,
China) and labelled with a goat anti-rabbit secondary antibody conju-
gated to Cy3. Foxp3 was detected with a mouse anti-human antibody
(Santa, USA) and labelled with a goat anti-mouse secondary antibody
conjugated to FITC. Nuclei were costained using DAPI.2.9. Statistics
Statistical differences between groups were assessed by the non-
parametric Mann-Whitney U-test for two groups and Kruskal-Wallis
test for more than two groups. Bonferroni-Dunn's correction method
was applied for post hoc multiple pair-wise comparisons. Spearman's
rank correlation coefﬁcient estimated the degree of association betweenFig. 1.Mutations of Enho in MPO-ANCA associated lung injury. (a) c.127T N A (p.Ser43Thr) mut
(p.Tyr72Tyr) mutation. (d) c.*61T N Cmutation. (e) c.*238T N Cmutation. (f) c.-62C N T mutatio
peptide domain (1-33aa, green), and a mat_peptide domain (34-76aa, light blue) which conta
phosphorylation site (Y72). Using the Motif Scan program, there are an N-myristoylation pa
tyrosine kinase phosphorylation site (positions 65–72, KPSHEQSY). Bottom panel shows sch
serum concentration of adropin in patients with MPO-ANCA-related pneumonia (MPO-ANCA
(i) Serum concentration of adropin in MPO-ANCA associated lung injury patients with differentwo variables. Signiﬁcancewas calculated at P b 0.05 by GraphPad Prism
5 (La Jolla, CA).
3. Results
3.1. Clinical Characteristics
We identiﬁed all of the 152 patients showing higher serum levels of
MPO-ANCA (26.90–420.96 EU). Data of other autoimmune antibodies
available at the time of biopsy were positive for RF (12/152), ANA (6/
152), SS-A (12/152), Jo-1 (0/152), RNP (0/152), Scl-70 (0/152), and
SS-B (13/152). The serum levels of hyaluronic acid, type IV collagen,
and laminin were signiﬁcantly increased in the patients with MPO-
ANCA associated lung injury, which suggests that the patients develop
into ﬁbrosis. Baseline characteristics in the different genotype showed
in Table 1.
3.2. Identiﬁcation of Heterozygous Mutations in Enho
We identiﬁed two heterozygous protein-altering variants, that is, 6
patients with c.127T N A (ENSP00000382675.2: p.Ser43Thr) (Fig. 1a)
and 5 patients with c.168T N G (p.Cys56Trp) amino acid substitution
(Fig. 1b). Moreover, c.216C N T heterozygous mutation
(ENST00000399775.2: p.Tyr72Tyr) (Fig. 1c) was found in one patient,
which was located at the predicted tyrosine phosphorylation site
(Wang et al., 2015; Huttlin et al., 2010; Blom et al., 1999). Another 13
patients harboredmutations located at the 3′UTR of Enho, i.e., 3 patients
with c.*61T N C (Fig. 1d) and 10 patients with c.*238T N C (Fig. 1e). 2
patients were identiﬁed with c.-62C N T located at the 5′ UTR of Enho
(Fig. 1f). However, none of the mutations were found in the control
participants.
The median levels of serum adropin before therapy were signiﬁ-
cantly lower in the patients with MPO-ANCA associated lung injuryation. (b) c.168T N Gmutation result in p.Cys56Trp amino acid substitution. (c) c.216C N T
n. (g) Top panel shows scheme of the adropin domain structure. Adropin contains a signal
ining predicted serine phosphorylation sites (S43, 45, 47, 48, 51, 52 and 67) and tyrosine
tter (MGAAISQ), a casein kinase II phosphorylation site (positions 43–46, SLSE), and a
eme of the location of Enho mutations causing MPO-ANCA-related pneumonia. (h) The
associated lung injury), healthy subjects, pulmonary bulla, lung cancer, and pneumonia.
t Enho genotypes. (j) MicroRNA-mRNA interaction network of Enho.
327F. Gao et al. / EBioMedicine 9 (2016) 324–335than that of the healthy subjects (n = 152, 72.94 pg/mL and n =
220, 173.08 pg/mL, respectively; P b 0.0001). In addition, it was
also lower than the patients with pulmonary bulla (n = 30,231.10 pg/mL; P b 0.0001), lung cancer (n = 33, 272.21 pg/mL;
P b 0.0001), and pneumonia (n = 40, 213.05 pg/mL; P b 0.0001)
(Fig. 1h).
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three groups according to Enho genotypes, patients with Enho exon
mutations (Ser43Thr, Cys56Trp, and Tyr72Tyr) (Enho-Exon-M, n =
12), patients with 5′ UTR or 3′ UTR mutations of Enho (Enho-Intron-
M, n = 15), and patients with wild-type of Enho (Enho-W, n = 125).
It was found that serum adropin of the patients with Enho exon muta-
tions was signiﬁcantly lower as compared to the patients with wild-
type Enho (36.91 pg/mL and 71.79 pg/mL, respectively, P b 0.0001)
(Fig. 1i).
Furthermore, a microRNA-mRNA interaction network was
constructed and the disturbed biological pathways were identiﬁed fol-
lowing adropin knockout in order to explore the pathogenesis and oc-
currence of adropin-deﬁciency associated with MPO-ANCA associated
lung injury (http://www.ingenuity.com/products/ipa). It showed that
Enhowasmainly regulated by miRNAs, along with the only gene, mito-
chondrial uncoupling protein 1 (UCP1), which is responsible for the
nonshivering thermogenesis in brown adipose tissue (BAT) (Fig. 1j)
(Fedorenko et al., 2012).
3.3. Pathogenesis of MPO-ANCA Associated Lung Vasculitis in AdrKO Mice
Adropin cDNA from human, mouse, rat, and pig are similar (Goetze
and Albrethsen, 2014). To investigate the possibility that adropin serves
as an endogenous vasoprotective substance, we used AdrKO mice
(Fig. 2a) for assessing the effect of adropin-deﬁciency on the formation
of neointima or vasculitis. F2 intercrossed mice were genotyped by
Sanger sequencing (Fig. 2b). Hematoxylin and eosin (H&E) staining of
the biopsy from AdrKOmice revealed the typical histopathological fea-
tures of vasculitis and pneumonia, including red-blood-cell extravasa-
tion, a dense perivascular, predominantly neutrophilic inﬁltrate in the
involved blood vessel walls or bronchus of the lung tissue (Fig. 2c),
which is a common histopathologic feature found in human MPO-
ANCA-related pulmonary hemorrhage. Serum levels of MPO, CRP,
TNF-α, AECA, OPN, and ET-1 increased by the age of 8 weeks indicating
tissue damage, but serum PR3 was not signiﬁcantly different between
AdrKO and WT mice (P = 0.1362) (Fig. 2d), to some extent, it may
show the distinct genetic background for PR3-AAV and MPO-AAV. In
AdrHET mice, serum adropin levels were inversely associated with
CRP (r = −0.5034, P = 0.0169), TNF-α (r =−0.4430, P = 0.0389),
AECA (r = −0.3643, P = 0.0956), OPN (r = −0.3846, P = 0.0772),
ET-1 (r = −0.6988, P = 0.0003), and insulin (INS) (r = −0.4015,
P = 0.0640), respectively (Fig. 2e). A drastic increase in the immune
cell populations, CD3, CD20, and CD38 positive cells in AdrKO lung tis-
sue was deﬁned by histological evaluations. In contrast, the wild-type
displayed almost no detectable inﬂammatory cells (Fig. 2f).
3.4. Expression Proﬁling of Lung Tissue Isolates by RNA-seq
We observed a strong transcriptional interferon response gene sig-
nature and decreased levels of adropin and other interferon-induced
cytokines in the lung tissues. The proﬁling also identiﬁed a series of
genes whose expression level differed signiﬁcantly between the two
groups (KO vs. WT), but not between the samples within the same
group (Fig. 3a). The up-regulated genes were mainly observed in
enriched iron ion binding, cilia, and radioactive stimulation of the
gene ontology in AdrKO mice. The down-regulated genes are mainly
enriched in the function of myocardial development and blood circula-
tion (Fig. 3b).
Moreover, increased expression of adhesion molecules such as vas-
cular cell adhesion molecule-1 (VCAM-1), inﬂammatory cytokines
such as interleukins-1α, -1β, -6, -33, and TNF-αwas detected by RNA-
seq (Fig. 3c). Similar to human MPO-AAV that is presented as chronic
lung hemorrhage, MPOwas also signiﬁcantly increased in the lungs tis-
sue of AdrKO mice (P b 0.0001), while PR3 was signiﬁcantly lower in
AdrKO than that of WT mice (P= 0.0167) (Fig. 3d).3.5. AdrKO Mice Exhibit Reduced eNOS (Ser1177) and Akt1 (Ser473)
Phosphorylation
RepresentativeWestern blots showed that pAkt1 (T450), total Akt1,
total eNOS, and Mapk1 levels were unaffected by adropin, but AdrKO
mice exhibited reduced Akt1 (Ser473) phosphorylation. Furthermore,
adropin-elicited eNOS phosphorylation at Ser1177 was signiﬁcantly
lower in the lung tissues from AdrKOmice than that of the negative lit-
termates (Fig. 4).
3.6. Evaluation of Endothelial Cells (ECs) in AdrKO Mice
Because early re-endothelialization after vascular injury is known to
attenuate neointimal formation, we evaluated the EC marker CD31 by
immunostaining (Fig. 5a) and immunoﬂuorescence (Fig. 5b), and ob-
served that CD31 is signiﬁcantly expressed in AdrKO thanWT mice, in-
dicating endothelial cells higher proliferative and vascular injury in
AdrKOmice. We next investigated whether AdrKOmice developed au-
toantibodies against endothelial cell by immunohistochemical staining.
VCAM-1 was signiﬁcantly increased in the 8-week-old AdrKO mice
(Fig. 5a). Furthermore, tissue immunoﬂuorescence analysis showed
CD31 overlap with VCAM-1 in the endothelial and smooth muscle
layers, which conﬁrmed that AdrKO mice developed autoantibodies
against endothelial cell and more than the WT mice (Fig. 5a, b).
Enho−/− epithelial cell expression of osteopontin (OPN) was signiﬁ-
cantly increased and the result was reﬂected as such by RNA-seq
(P = 0.0090) (Fig. 5c) and immunohistochemical staining (Fig. 5a).
We also estimated the level of cells proliferative activity in vivo by im-
munostaining for Ki-67 in the endothelial and smooth muscle layers.
The number of Ki-67-positive cells was signiﬁcantly higher in neointi-
mal lesions from AdrKO than that of the WT mice (Fig. 5a), indicating
high cell proliferative capacity in adropin-decreased mice.
3.7. Adropin via VEGFR2-PI3K-AKT1 Pathways and Resulting in Autoim-
mune Inﬂammation
It has been reported that adropin-induced Akt1 phosphorylation is
dependent on PI3K. Furthermore, it is also suggested that VEGFR2 is a
target of adropin with resultant downstream effects on PI3K-mediated
eNOS activation (Lovren et al., 2010). Thus, we investigated the co-local-
ization of the three proteins in the endothelial and smoothmuscle layers.
It showed the lung tissues fromAdrKO expressed lower Akt1 than that of
the WT mice (Fig. 6a, b). For cellular localization of proteins, tissue im-
munoﬂuorescence analysis for staining in the endothelial and smooth
muscle layers, showed that the overlap of Akt1 and VEGFR2, and Akt1
and PI3K (yellow staining in the merged image) was also lower in
AdrKOmice (Fig. 6a, b) indicating that adropin-deﬁciency reduced Akt1.
The production of isotype-switched autoantibodies in AAV suggests
the involvement of CD4+ helper T cells in the autoimmune process
(Free et al., 2013). In this study, we found that the proportion and an
absolute number of CD4+Foxp3+ (Treg) cells were signiﬁcantly
decreased in lung tissues of AdrKO mice when compared with the
matched Enho+/+ littermates which further suggested that adropin-
deﬁciency is associated with inhibition of Treg cells (Fig. 6c).
4. Discussion
ANCA-associated vasculitis (AVV) is a life-threatening condition and
patients typically sustain renal and pulmonary injury (Holguin et al.,
2008; Lally and Spiera, 2015; Cid, 2012). It has further conﬁrmed that
the impaired endothelial function contributes to the development and
progression of diverse vascular, inﬂammatory, and pulmonary hemor-
rhage (Verma et al., 2003, Dzau et al., 2002). Moreover, endothelium
and inﬂammatory cell inﬁltration of the neointima is intimately related
to oxidative stress (Duckers et al., 2001). In the present study, we
showed Enhomutations/adropin-deﬁciency results in the activation of
Fig. 2. AdrKO mice exhibit MPO-ANCA associated lung injury. (a) Enho single-guide (sg) RNA and target site. The sgRNA target site is located at exon 2, which encodes amino acids
upstream of the adropin. (b) Genotyping of F2 intercrossed mice. (c) Development of pneumonia and vasculitis visualized by H&E staining from AdrKO mice. Pneumonia which
depicted by double headed arrow (Original magniﬁcation: 400×), vasculitis depicted with green outline (Original magniﬁcation: 400×), and red-blood-cell extravasation with black
arrowheads (Original magniﬁcation: 1000×). Scale bar, 100 μm. (d) Serum MPO, CRP, TNF-α, AECA, OPN, and ET-1 were increased in AdrKO mice compared with wild type. n = 8
mice per group. (e) In AdrHET, serum adropin levels were inversely associated with CRP, TNF-α, AECA, OPN, and ET-1. n= 43. (f) Immune cell populations in patient with p.Ser43Thr
mutation and AdrKO mice. CD3-positive T-lymphocytes, CD20 immunostaining demonstrates multiple B-cell aggregates, and CD38 demonstrates plasmacytic aggregates are present
within the lesion in patient and AdrKO mice. Scale bar, 100 μm.
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Fig. 2 (continued).
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Fig. 3. Identiﬁcation of the differentially expressed genes of lungs tissue from AdrKOmice and negative littermates. (a) Differential gene expression pattern cluster analysis. Color depth in
the heatmap represents the different expression levels (heatmap) (left). Levels of differentially expressed genes among samples (right). n=3mice per group. AdrKO: K1-1, K3, K4-2.Wild
type (negative littermates):W1-1,W2-1,W3-1. (b) GeneOntology (GO) enrichment of differentially expressed genes. (c) The upregulated angiogenesis-associated genes (The number of
label above the bar is fold change obtained from RNA-seq data). (d) MPO was increased in AdrKO mice (The number of label above the bar is fold change obtained from RNA-seq data).
332 F. Gao et al. / EBioMedicine 9 (2016) 324–335endothelial cells during neutrophil recruitment and neutrophil-endo-
thelial cell interactions under TNF-α-induced vascular inﬂammation
to be associated with MPO-ANCA associated lung injury.
We identiﬁed the serum concentration of adropin was signiﬁcantly
lower in the patients, and we bring hypothesis whether it is associated
with Enhomutations. To our surprise, therewere not all patients carried
Enhomutations. In order to explore the pathogenesis and occurrence of
adropin associated with MPO-ANCA-related pulmonary hemorrhage or
ﬁbrosis. AmicroRNA-mRNA interaction networkwas constructed and it
showed that Enho is mainly regulated by miRNAs which revealed that
adropin low expression in wild-type patients may be related to the reg-
ulation of micro-RNA. To gain more insight into the genotype-pheno-
type correlation in adropin-deﬁciency, we used AdrKO mice to
investigate the genotype-proteotype-phenotype correlation in patients
with adropin-deﬁciency.Fig. 4. AdrKO mice exhibit reduced eNOS (Ser1177) and Akt1 (Ser473) phosphorylation.
Phosphorylation of Akt1 on serine 473 (pAkt1, S473), threonine 450 (pAkt1, T450), and
total Akt1 protein. Phosphorylation of eNOS Ser1177 (peNOS, Ser1177) and total eNOS
protein. Gapdh levels were assessed as a control for loading. AdrKO mice: K1, K2, and
K3. Negative littermates: W1, W2, and W3. n= 3mice per group.Enho−/−mice showed MPO-ANCA-related pulmonary hemorrhage
typical of vasculitis, including red-blood-cell extravasation, a dense
perivascular, and predominantly neutrophilic inﬁltrate in the vascular
or bronchus, developed autoantibodies against endothelial cell
(VCAM-1 elevated), and autoimmunity pulmonary injury (CD3+,
CD20+, and CD38+ cell inﬁltrate). Elevated serum levels of MPO, CRP,
TNF-α, AECA, ET-1, and OPN were detected in AdrKO mice. Further-
more, our study describes the RNA-seq proﬁling of the pneumonia
fromAdrKOmice. 507 geneswere identiﬁed as vascular or autoimmune
target candidates. Some examples are cyclin E andmitogen- and stress-
activated protein kinases 1 (MSK1) which conﬁrmed cell cycle G1/S
progression, monocyte chemoattractant protein-1 gene (MCP-1) for
phagocyte recruitment or inﬂammation, and atrial natriuretic peptide
for vascular tone. As compared to the lean mice, the deﬁciency of
adropin decreased Akt1 (Ser473) phosphorylation and downregulated
peNOS expression in the lungs of AdrKO mice. It has been reported
that Treg cells expressing Foxp3 control the onset and the development
of autoimmune disease (Sakaguchi et al., 1995). So, we hypothesized
that adropin-deﬁciencymaybe the driver of Treg cells impairment in pa-
tients with MPO-ANCA-related lung disease. In vivo, it showed that the
proportion and an absolute number of CD4+Foxp3+ cells were signiﬁ-
cantly decreased in AdrKO mice and these results provide further sup-
port for the hypothesis that adropin is a peptide hormone involved in
regulating vascular inﬂammation and autoimmunity.
Adropin may be linked to insulin resistance and the pathogenesis of
various diseases through altered immune responses (Ganesh Kumar et
al., 2012; Hotamisligil, 2006; Bapat et al., 2015). In this study, we have
demonstrated that VCAM-1 and CD31 were signiﬁcantly increased in
AdrKO mice and the two proteins were co-localized in the endothelial
and smooth muscle layers which conﬁrmed that antibody (VCAM-1)
against endothelial cell (Kaplanski et al., 2005). This may be another
manifestation or characteristic of ANCA associated vasculitis. Further-
more, adropin-deﬁciency leads to the activation of vascular endotheli-
um expressing adhesion molecules which may accelerate and localize
foci to the inﬂammatory processes (Graphical abstract).
Although there were other genes mutations detected in autoim-
mune-mediated lung disease and led to the production of anti-ANCA
antibodies, their clinical manifestations may be signiﬁcantly different.
Enho mutations cause MPO-ANCA-related pulmonary hemorrhage,
whopresentedwith acute renal or respiratory failure, or both. However,
its greatest feature is that almost all patients with arthritis in coatomer
subunit alpha (COPA)mutations (Watkin et al., 2015) and stimulator of
interferon genes (STING)-associated vasculopathy presented in early
infancy with systemic inﬂammation and violaceous, scaling lesions of
ﬁngers, toes, nose, cheeks, and ears and did not respond to hormone
therapy (Liu et al., 2014). Half of the patients had severe interstitial
lung disease and autoantibodies (ANCAs) that are seen in vasculitis
Fig. 5.Adropin-deﬁciency inﬂuences theproliferation of VSMCs and ECs. (a) Immunohistochemical stainingof CD31, VCAM-1, OPN, andKi-67. CD31positive in the endothelial and smooth
muscle layers depictedwith green outline. Scale bar, 100 μm. Original magniﬁcation: 400×. (b) Tissue immunoﬂuorescence analysis showed the CD31 overlap with VCAM-1. A blue DAPI
counterstain was used. Original magniﬁcation: 400×. (c) OPN express in lungs tissue from AdrKO andWT mice by RNA-seq.
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Fig. 6. In vivo evidence for co-localization of VEGFR2-PI3K-Akt1 and loss of Treg cells in AdrKO mice. (a) Confocal immunoﬂuorescence analysis showing diminutive areas of colocalized
DNA in blue, VEGFR2 in red and Akt1 in green, indicates reduced Akt1 formation in AdrKO mice. (b) Confocal immunoﬂuorescence analysis showing small areas of co-localized DNA in
blue, PI3K in red and Akt1 in green, in the endothelial and smooth muscle layers, indicates decreased Akt1 and PI3K activity in AdrKO mice. (c) Colocalization of DNA (blue), CD4 (red)
and Foxp3 (green) indicates Treg cells formation. Original magniﬁcation: 400×.
334 F. Gao et al. / EBioMedicine 9 (2016) 324–335and the antiphospholipid syndrome, but these antibodies disappeared
over time (Liu et al., 2014). The role of genetic variation in the immune
mechanism remains to be further studied.
In conclusion, Enhomutations or adropin-deﬁciency plays a critical
role in activating endothelial cells during neutrophil recruitment and
neutrophil-endothelium cell interactions under IL-1 and TNF-α-in-
duced vascular inﬂammation and increases susceptibility to MPO-
ANCA associated lung injury.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.ebiom.2016.05.036.
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